{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:22:23Z","timestamp":1790954543481,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004774","name":"New England Biolabs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 R01 AI116441"],"award-info":[{"award-number":["5 R01 AI116441"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 R01 AI116441"],"award-info":[{"award-number":["5 R01 AI116441"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Serum N-glycan profiling studies during the past decades have shown robust associations between N-glycan changes and various biological conditions, including infections, in humans. Similar studies are scarcer for other mammals, despite the tremendous potential of serum N-glycans as biomarkers for infectious diseases in animal models of human disease and in the veterinary context. To expand the knowledge of serum N-glycan profiles in important mammalian model systems, in this study, we combined MALDI-TOF-MS analysis and HILIC-UPLC profiling of released N-glycans together with glycosidase treatments to characterize the glycan structures present in rhesus macaque serum. We used this baseline to monitor changes in serum N-glycans during infection with <jats:italic>Brugia malayi<\/jats:italic>, a parasitic nematode of humans responsible for lymphatic filariasis, in a longitudinal cohort of infected rhesus macaques. Alterations of the HILIC-UPLC profile, notably of abundant structures, became evident as early as 5\u00a0weeks post-infection. Given its prominent role in the immune response, contribution of immunoglobulin G to serum N-glycans was investigated. Finally, comparison with similar N-glycan profiling performed during infection with the dog heartworm <jats:italic>Dirofilaria immitis<\/jats:italic> suggests that many changes observed in rhesus macaque serum N-glycans are specific for lymphatic filariasis.<\/jats:p>","DOI":"10.1038\/s41598-022-19964-1","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T18:03:09Z","timestamp":1663783389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Alteration of rhesus macaque serum N-glycome during infection with the human parasitic filarial nematode Brugia malayi"],"prefix":"10.1038","volume":"12","author":[{"given":"Laudine M. C.","family":"Petralia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esrath","family":"Santha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Janina","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Linh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul B.","family":"Ganatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Taron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaswamy","family":"Kalyanasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"van Diepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis H.","family":"Hokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"19964_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","volume":"33","author":"F Clerc","year":"2016","unstructured":"Clerc, F. et al. Human plasma protein N-glycosylation. Glycoconj. J. 33, 309\u2013343 (2016).","journal-title":"Glycoconj. J."},{"key":"19964_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki, A. Biological roles of glycans. Glycobiology 27, 3\u201349 (2017).","journal-title":"Glycobiology"},{"key":"19964_CR3","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/pr2011439","volume":"11","author":"D Aldredge","year":"2012","unstructured":"Aldredge, D., An, H. J., Tang, N., Waddell, K. & Lebrilla, C. B. Annotation of a serum N-glycan library for rapid identification of structures.pdf. J. Proteome Res. 11, 1958\u20131968 (2012).","journal-title":"J. Proteome Res."},{"key":"19964_CR4","doi-asserted-by":"crossref","unstructured":"Klein, A. Human total serum N-glycome. Advances in Clinical Chemistry (Advances in Clinical Chemistry, 2008).","DOI":"10.1016\/S0065-2423(08)00402-2"},{"key":"19964_CR5","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1021\/ac800630x","volume":"80","author":"LR Ruhaak","year":"2008","unstructured":"Ruhaak, L. R. et al. Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. Anal. Chem. 80, 6119\u20136126 (2008).","journal-title":"Anal. Chem."},{"key":"19964_CR6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1039\/C5IB00130G","volume":"7","author":"H Stockmann","year":"2015","unstructured":"Stockmann, H., O\u2019Flaherty, R., Adamczyk, B., Saldova, R. & Rudd, P. M. Automated, high-throughput serum glycoprofiling platform. Integr. Biol. 7, 1026\u20131032 (2015).","journal-title":"Integr. Biol."},{"key":"19964_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/glycob\/cwp134","volume":"19","author":"O Gornik","year":"2009","unstructured":"Gornik, O. et al. Stability of N-glycan profiles in human plasma. Glycobiology 19, 1547\u20131553 (2009).","journal-title":"Glycobiology"},{"key":"19964_CR8","doi-asserted-by":"publisher","unstructured":"Ding, N. et al. Human serum N -glycan profiles are age and sex dependent. Age Ageing 568\u2013575 (2011) doi:https:\/\/doi.org\/10.1093\/ageing\/afr084.","DOI":"10.1093\/ageing\/afr084"},{"key":"19964_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0209515","volume":"13","author":"AG Gebrehiwot","year":"2018","unstructured":"Gebrehiwot, A. G. et al. Healthy human serum N -glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers. PLoS ONE 13, 1\u201323 (2018).","journal-title":"PLoS ONE"},{"key":"19964_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-26805-7","volume":"8","author":"M Doherty","year":"2018","unstructured":"Doherty, M. et al. Plasma N-glycans in colorectal cancer risk. Sci. Rep. 8, 1\u201312 (2018).","journal-title":"Sci. Rep."},{"key":"19964_CR11","doi-asserted-by":"crossref","unstructured":"Hu, M., Lan, Y., Lu, A., Ma, X. & Zhang, L. Glycan-based biomarkers for diagnosis of cancers and other diseases\u202f: Past , present , and future. Progress in Molecular Biology and Translational Science vol. 162 (Elsevier Inc., 2019).","DOI":"10.1016\/bs.pmbts.2018.12.002"},{"key":"19964_CR12","doi-asserted-by":"crossref","unstructured":"Kirwan, A., Utratna, M., Dwyer, M. E. O., Joshi, L. & Kilcoyne, M. Glycosylation-based serum biomarkers for cancer diagnostics and prognostics. Biomed Res. Int. 2015, (2015).","DOI":"10.1155\/2015\/490531"},{"key":"19964_CR13","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1158\/1078-0432.CCR-16-1500","volume":"23","author":"X Verhelst","year":"2017","unstructured":"Verhelst, X. et al. A glycomics-based test predicts the development of hepatocellular carcinoma in cirrhosis. Clin. Cancer Res. 23, 2750\u20132758 (2017).","journal-title":"Clin. Cancer Res."},{"key":"19964_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/dc19-1507","volume":"43","author":"C Wittenbecher","year":"2020","unstructured":"Wittenbecher, C. et al. Plasma N-glycans as emerging biomarkers of cardiometabolic risk\u202f: a prospective investigation in the EPIC-potsdam cohort study. Diabetes Care 43, 1\u20138 (2020).","journal-title":"Diabetes Care"},{"key":"19964_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1074\/mcp.RA117.000454","volume":"18","author":"KR Reiding","year":"2019","unstructured":"Reiding, K. R. et al. High-throughput serum N-glycomics\u202f: method comparison and application to study rheumatoid arthritis and pregnancy-associated changes. Mol. Cell. Proteomics 18, 3\u201315 (2019).","journal-title":"Mol. Cell. Proteomics"},{"key":"19964_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2018.05.030","volume":"155","author":"F Clerc","year":"2018","unstructured":"Clerc, F. et al. Plasma N-glycan signatures are associated with features of inflammatory bowel diseases. Gastroenterology 155, 829\u2013843 (2018).","journal-title":"Gastroenterology"},{"key":"19964_CR17","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1021\/acs.jproteome.5b00709","volume":"14","author":"R Saldova","year":"2015","unstructured":"Saldova, R. et al. N-glycosylation of serum IgG and total glycoproteins in MAN1B1 deficiency. J. Proteome Res. 14, 4402\u20134412 (2015).","journal-title":"J. Proteome Res."},{"key":"19964_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ab.2013.07.037","volume":"442","author":"B Xia","year":"2013","unstructured":"Xia, B. et al. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation. Anal. Biochem. 442, 178\u2013185 (2013).","journal-title":"Anal. Biochem."},{"key":"19964_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1074\/mcp.M800470-MCP200","volume":"8","author":"D Vanderschaeghe","year":"2009","unstructured":"Vanderschaeghe, D. et al. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol. Cell. Proteomics 8, 986\u2013994 (2009).","journal-title":"Mol. Cell. Proteomics"},{"key":"19964_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbagen.2007.06.012","volume":"1780","author":"A Kobata","year":"2008","unstructured":"Kobata, A. The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles. Biochim. Biophys. Acta 1780, 472\u2013478 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"19964_CR21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.bbagen.2011.12.004","volume":"1820","author":"O Gornik","year":"2012","unstructured":"Gornik, O., Pavi, T. & Lauc, G. Alternative glycosylation modulates function of IgG and other proteins: implications on evolution and disease. Biochim. Biophys. Acta 1820, 1318\u20131326 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"19964_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","volume":"333","author":"I Gudelj","year":"2018","unstructured":"Gudelj, I., Lauc, G. & Pezer, M. Immunoglobulin G glycosylation in aging and diseases. Cell. Immunol. 333, 65\u201379 (2018).","journal-title":"Cell. Immunol."},{"key":"19964_CR23","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","volume":"13","author":"A Bondt","year":"2014","unstructured":"Bondt, A. et al. Immunoglobulin G (IgG) fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol. Cell. Proteomics 13, 3029\u20133039 (2014).","journal-title":"Mol. Cell. Proteomics"},{"key":"19964_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/pmic.200800715","volume":"9","author":"C Huhn","year":"2009","unstructured":"Huhn, C., Selman, M. H. J., Ruhaak, L. R. & Deelder, A. M. IgG glycosylation analysis. Proteomics 9, 882\u2013913 (2009).","journal-title":"Proteomics"},{"key":"19964_CR25","doi-asserted-by":"crossref","unstructured":"Sto\u0308ckmann, H., Adamczyk, B., Hayes, J. & Rudd, P. M. Automated high-throughput IgG-antibody glycoprofiling platform. Anal. Chem. 8841\u20138849 (2013).","DOI":"10.1021\/ac402068r"},{"key":"19964_CR26","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1002\/pmic.200700289","volume":"7","author":"M Wuhrer","year":"2007","unstructured":"Wuhrer, M. et al. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 7, 4070\u20134081 (2007).","journal-title":"Proteomics"},{"key":"19964_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jprot.2014.12.020","volume":"116","author":"W Yuan","year":"2015","unstructured":"Yuan, W., Sanda, M., Wu, J., Koomen, J. & Goldman, R. Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease. J. Proteomics 116, 24\u201333 (2015).","journal-title":"J. Proteomics"},{"key":"19964_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/glycob\/10.5.477","volume":"10","author":"TS Raju","year":"2000","unstructured":"Raju, T. S., Briggs, J. B., Borge, S. M. & Jones, A. J. S. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10, 477\u2013486 (2000).","journal-title":"Glycobiology"},{"key":"19964_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.carres.2014.01.018","volume":"389","author":"B Adamczyk","year":"2014","unstructured":"Adamczyk, B. et al. Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species. Carbohydr. Res. 389, 174\u2013185 (2014).","journal-title":"Carbohydr. Res."},{"key":"19964_CR30","first-page":"949","volume":"10615","author":"J Hamako","year":"1993","unstructured":"Hamako, J., Matsui, T., Ozeki, Y., Mizuochi, T. & Titani, K. Comparative studies of asparagine-linked sugar chains of immunoglobulin G from eleven mammalian. Comp. Biochem. Physiol. 10615, 949\u2013954 (1993).","journal-title":"Comp. Biochem. Physiol."},{"key":"19964_CR31","doi-asserted-by":"crossref","first-page":"G833","DOI":"10.1152\/ajpcell.00003.2010","volume":"300","author":"B Blomme","year":"2011","unstructured":"Blomme, B. et al. Alterations of serum protein N -glycosylation in two mouse models of chronic liver disease are hepatocyte and not B cell driven. Am. J. Physiol. Liver Physiol. 300, G833\u2013G842 (2011).","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"19964_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/glycob\/cwy070","volume":"28","author":"A Behrens","year":"2018","unstructured":"Behrens, A. et al. Glycosylation profiling of dog serum reveals differences compared to human serum. Anal. Glycobiol. 28, 825\u2013831 (2018).","journal-title":"Anal. Glycobiol."},{"key":"19964_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/19420862.2016.1274845","volume":"9","author":"AW Boesch","year":"2017","unstructured":"Boesch, A. W., Miles, A. R., Chan, Y. N., Osei-owusu, N. Y. & Ackerman, M. E. IgG Fc variant cross-reactivity between human and rhesus macaque FcgRs. MAbs 9, 455\u2013465 (2017).","journal-title":"MAbs"},{"key":"19964_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajp.22281","volume":"76","author":"KA Phillips","year":"2015","unstructured":"Phillips, K. A. et al. Why primate models matter. Am. J. Primatol. 76, 801\u2013827 (2015).","journal-title":"Am. J. Primatol."},{"key":"19964_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00697","volume":"10","author":"AR Crowley","year":"2019","unstructured":"Crowley, A. R. & Ackerman, M. E. Mind the gap: how interspecies variability in IgG and its receptors may complicate comparisons of human and non-human primate effector function. Front. Immunol. 10, 1\u201319 (2019).","journal-title":"Front. Immunol."},{"key":"19964_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.754710","volume":"12","author":"AR Crowley","year":"2021","unstructured":"Crowley, A. R. et al. Biophysical evaluation of rhesus macaque Fc gamma receptors reveals similar IgG Fc glycoform preferences to human receptors. Front. Immunol. 12, 1\u20139 (2021).","journal-title":"Front. Immunol."},{"key":"19964_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jim.2014.12.004","volume":"417","author":"AE Mahan","year":"2016","unstructured":"Mahan, A. E. et al. A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. J. Immunol. Methods 417, 34\u201344 (2016).","journal-title":"J. Immunol. Methods"},{"key":"19964_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/expr.1998.4312","volume":"90","author":"GH Giambartolomei","year":"1998","unstructured":"Giambartolomei, G. H., Lasater, B. L., Villinger, F. & Dennis, V. A. Diminished production of T helper 1 cytokines and lack of induction of IL-2R+ T cells correlate with T-cell unresponsiveness in rhesus monkeys chronically infected with Brugia Malayi. Exp. Parasitol. 90, 77\u201385 (1998).","journal-title":"Exp. Parasitol."},{"key":"19964_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1006\/expr.1998.4300","volume":"89","author":"VA Dennis","year":"1998","unstructured":"Dennis, V. A., Lasater, B. L., Blanchard, J. L., Lowrie, R. C. & Campeau, R. J. Histopathological, lymphoscintigraphical, and immunological changes in the inguinal lymph nodes of rhesus monkeys during the early course of infection with Brugia malayi. Exp. Parasitol. 89, 143\u2013152 (1998).","journal-title":"Exp. Parasitol."},{"key":"19964_CR40","unstructured":"WHO. WHO | Lymphatic filariasis. Who http:\/\/www.who.int\/mediacentre\/factsheets\/fs102\/en\/ (2014)."},{"key":"19964_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0007192","volume":"13","author":"S Wanji","year":"2019","unstructured":"Wanji, S. et al. Mapping of lymphatic filariasis in loiasis areas\u202f: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon. PLoS Negl. Trop. Dis. 13, 1\u201315 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"19964_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cnur.2019.02.007","volume":"54","author":"GB Lourens","year":"2019","unstructured":"Lourens, G. B. & Ferrell, D. K. Lymphatic filariasis. Nurs. Clin. North Am. 54, 181\u2013192 (2019).","journal-title":"Nurs. Clin. North Am."},{"key":"19964_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0000998","volume":"5","author":"MY Osei-atweneboana","year":"2011","unstructured":"Osei-atweneboana, M. Y. et al. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl. Trop. Dis. 5, 1\u201311 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"19964_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","volume":"376","author":"MJ Taylor","year":"2010","unstructured":"Taylor, M. J., Hoerauf, A. & Bockarie, M. Lymphatic filariasis and onchocerciasis. Lancet 376, 1175\u20131185 (2010).","journal-title":"Lancet"},{"key":"19964_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1017\/S003118200600076X","volume":"133","author":"AE Schwab","year":"2006","unstructured":"Schwab, A. E., Churcher, T. S., Schwab, A. J. & Prichard, R. K. Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti. Parasitology 133, 589\u2013601 (2006).","journal-title":"Parasitology"},{"key":"19964_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0009373","volume":"15","author":"A Casulli","year":"2021","unstructured":"Casulli, A. New global targets for NTDs in the who roadmap 2021\u20132030. PLoS Negl. Trop. Dis. 15, 1\u201310 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"19964_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/glycob\/cwaa018","volume":"30","author":"EB Irvine","year":"2020","unstructured":"Irvine, E. B. & Alter, G. Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases. Glycobiology 30, 241\u2013253 (2020).","journal-title":"Glycobiology"},{"key":"19964_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"SE De Jong","year":"2016","unstructured":"De Jong, S. E. et al. IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci. Rep. 6, 1\u20139 (2016).","journal-title":"Sci. Rep."},{"key":"19964_CR49","doi-asserted-by":"crossref","unstructured":"Gardinassi, L. G. et al. Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin Fc N-glycosylation. MBio 5, (2014).","DOI":"10.1128\/mBio.01844-14"},{"key":"19964_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60681-4","volume":"10","author":"IF Rehan","year":"2020","unstructured":"Rehan, I. F. et al. Sialylated N-glycan profile during acute and chronic infections with Toxoplasma gondii in mice. Sci. Rep. 10, 1\u201317 (2020).","journal-title":"Sci. Rep."},{"key":"19964_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-35038-7","volume":"8","author":"A Behrens","year":"2018","unstructured":"Behrens, A. et al. Changes in canine serum N-glycosylation as a result of infection with the heartworm parasite Dirofilaria immitis. Sci. Rep. 8, 1\u20139 (2018).","journal-title":"Sci. Rep."},{"key":"19964_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/pim.12137","volume":"36","author":"NL O\u2019Regan","year":"2014","unstructured":"O\u2019Regan, N. L. et al. Filariasis asymptomatically infected donors have lower levels of disialylated IgG compared to endemic normals. Parasite Immunol. 36, 713\u2013720 (2014).","journal-title":"Parasite Immunol."},{"key":"19964_CR53","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1021\/ac500335t","volume":"86","author":"KR Reiding","year":"2014","unstructured":"Reiding, K. R., Blank, D., Kuijper, D. M., Deelder, A. M. & Wuhrer, M. High-throughput profiling of protein-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal. Chem. 86, 5784\u20135793 (2014).","journal-title":"Anal. Chem."},{"key":"19964_CR54","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.1021\/acs.analchem.5b02426","volume":"87","author":"N De Haan","year":"2015","unstructured":"De Haan, N. et al. Linkage-specific sialic acid derivatization for MALDI-TOF-MS profiling of IgG glycopeptides. Anal. Chem. 87, 8284\u20138291 (2015).","journal-title":"Anal. Chem."},{"key":"19964_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/(SICI)1097-0231(19960715)10:9<1027::AID-RCM634>3.0.CO;2-Y","volume":"10","author":"AK Powell","year":"1996","unstructured":"Powell, A. K. & Harvey, D. J. Stabilization of sialic acids in N-linked oligosaccharides and gangliosides for analysis by positive ion matrix-assisted laser desorption\/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 10, 1027\u20131032 (1996).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"19964_CR56","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1073\/pnas.95.20.11751","volume":"95","author":"H-H Chou","year":"1998","unstructured":"Chou, H.-H. et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 95, 11751\u201311756 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19964_CR57","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1128\/MCB.00379-07","volume":"27","author":"M Hedlund","year":"2007","unstructured":"Hedlund, M. et al. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol. Cell. Biol. 27, 4340\u20134346 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"19964_CR58","doi-asserted-by":"publisher","first-page":"28865","DOI":"10.1074\/jbc.M112.363549","volume":"287","author":"AK Bergfeld","year":"2012","unstructured":"Bergfeld, A. K., Pearce, O. M. T., Diaz, S. L., Pham, T. & Varki, A. Metabolism of vertebrate amino sugars with N-glycolyl groups-elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic. J. Biol. Chem. 287, 28865\u201328881 (2012).","journal-title":"J. Biol. Chem."},{"key":"19964_CR59","doi-asserted-by":"publisher","first-page":"28917","DOI":"10.1074\/jbc.M112.365056","volume":"287","author":"LRL Davies","year":"2012","unstructured":"Davies, L. R. L. et al. Metabolism of vertebrate amino sugars with N-glycolyl: resistance of alpha2-8-linked N-glycolylneuraminic acid to enzymatic cleavage. J. Biol. Chem. 287, 28917\u201328931 (2012).","journal-title":"J. Biol. Chem."},{"key":"19964_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/gbe\/evx251","volume":"10","author":"S Peri","year":"2018","unstructured":"Peri, S., Kulkarni, A., Feyertag, F., Berninsone, P. M. & Alvarez-ponce, D. Phylogenetic distribution of CMP-Neu5Ac hydroxylase (CMAH), the enzyme synthetizing the proinflammatory human xenoantigen Neu5Gc. Genome Biol. Evol. 10, 207\u2013219 (2018).","journal-title":"Genome Biol. Evol."},{"key":"19964_CR61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jprot.2015.11.022","volume":"135","author":"SA Springer","year":"2016","unstructured":"Springer, S. A. & Gagneux, P. Glycomics: revealing the dynamic ecology and evolution of sugar molecules. J. Proteomics 135, 90\u2013100 (2016).","journal-title":"J. Proteomics"},{"key":"19964_CR62","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1093\/bioinformatics\/btu305","volume":"30","author":"M Choi","year":"2014","unstructured":"Choi, M. et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics 30, 2524\u20132526 (2014).","journal-title":"Bioinformatics"},{"key":"19964_CR63","doi-asserted-by":"publisher","unstructured":"Stanley, P., Taniguchi, N. & Aebi, M. Chapter 9 N-glycans. in Essentials of glycobiology 3rd Edition (ed. Cold Spring Harbor Laboratory Press) doi:https:\/\/doi.org\/10.1101\/glycobiology.3e.009.","DOI":"10.1101\/glycobiology.3e.009"},{"key":"19964_CR64","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/cbic.201700077","volume":"18","author":"J Okerblom","year":"2017","unstructured":"Okerblom, J. & Varki, A. Biochemical, cellular, physiological, and pathological consequences of human loss of N-glycolylneuraminic acid. ChemBioChem 18, 1155\u20131171 (2017).","journal-title":"ChemBioChem"},{"key":"19964_CR65","doi-asserted-by":"crossref","unstructured":"Kaneko, Y., Nimmerjahn, F. & Ravetch, J. V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science (80-. ). 313, 670\u2013673 (2006).","DOI":"10.1126\/science.1129594"},{"key":"19964_CR66","doi-asserted-by":"crossref","unstructured":"Anthony, R. M. et al. A Recombinant Igg Fc that recapitulates the antiinflammatory activity of Ivig. Science (80-. ). 320, 373\u2013376 (2009).","DOI":"10.1126\/science.1154315"},{"key":"19964_CR67","doi-asserted-by":"crossref","unstructured":"Yu, X. et al. Engineering Hydrophobic protein\u2212carbohydrate interactions to Fine-Tune mAbs.pdf. J. Am. Chem. Soc. 135, 9723\u20139732 (2013).","DOI":"10.1021\/ja4014375"},{"key":"19964_CR68","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1080\/19420862.2016.1218586","volume":"8","author":"GP Subedi","year":"2016","unstructured":"Subedi, G. P. & Barb, A. W. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc \u03b3 receptor Fc g receptor. MAbs 8, 1512\u20131524 (2016).","journal-title":"MAbs"},{"key":"19964_CR69","doi-asserted-by":"crossref","unstructured":"Dekkers, G., Treffers, L., Plomp, R. & Bentlage, A. E. H. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement- mediated-effector activities. Front. Immunol. 8, (2017).","DOI":"10.3389\/fimmu.2017.00877"},{"key":"19964_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22199-8","volume":"8","author":"M Kiyoshi","year":"2018","unstructured":"Kiyoshi, M. et al. Assessing the heterogeneity of the Fc-Glycan of a therapeutic antibody using an engineered Fc \u03b3 receptor IIIa-immobilized column. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"19964_CR71","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/glycob\/cwg040","volume":"13","author":"N Callewaert","year":"2003","unstructured":"Callewaert, N., Schollen, E. & Vanhecke, A. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I. Glycobiology 13, 367\u2013375 (2003).","journal-title":"Glycobiology"},{"key":"19964_CR72","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1021\/pr800752c","volume":"8","author":"MA Comunale","year":"2009","unstructured":"Comunale, M. A. et al. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J. Proteome Res. 8, 595\u2013602 (2009).","journal-title":"J. Proteome Res."},{"key":"19964_CR73","doi-asserted-by":"crossref","unstructured":"Reily, C., Stewart, T. J., Renfrow, M. B. & Novak, J. Glycosylation in health and disease. Nat. Rev. Nephrol. 15, (2019).","DOI":"10.1038\/s41581-019-0129-4"},{"key":"19964_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcpro.2022.100201","volume":"21","author":"LMC Petralia","year":"2022","unstructured":"Petralia, L. M. C. et al. Mass spectrometric and glycan microarray-based characterization of the filarial nematode Brugia malayi glycome reveals anionic and zwitterionic glycan antigens. Mol. Cell. Proteomics 21, 1\u201322 (2022).","journal-title":"Mol. Cell. Proteomics"},{"key":"19964_CR75","first-page":"379","volume":"4","author":"A Klein","year":"2010","unstructured":"Klein, A., Carre, Y., Louvet, A., Michalski, J.-C. & Morelle, W. Immunoglobulins are the major glycoproteins involved in the modifications of total serum N-glycome in cirrhotic patients. Proteomics 4, 379\u2013393 (2010).","journal-title":"Proteomics"},{"key":"19964_CR76","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1128\/JVI.01600-07","volume":"82","author":"AS Mehta","year":"2008","unstructured":"Mehta, A. S. et al. Increased levels of galactose-deficient anti-gal immunoglobulin G in the Sera of Hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 82, 1259\u20131270 (2008).","journal-title":"J. Virol."},{"key":"19964_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.790895","volume":"13","author":"T Adjobimey","year":"2022","unstructured":"Adjobimey, T. & Hoerauf, A. Distinct N-linked immunoglobulin G glycosylation patterns are associated with chronic pathology and asymptomatic infections in human lymphatic filariasis. Front. Immunol. 13, 1\u201312 (2022).","journal-title":"Front. Immunol."},{"key":"19964_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-53384-y","volume":"9","author":"T Matsumoto","year":"2019","unstructured":"Matsumoto, T., Ha, S., Yoneyama, T. & Tobisawa, Y. Serum N -glycan profiling is a potential biomarker for castration- resistant prostate cancer. Sci. Rep. 9, 1\u20138 (2019).","journal-title":"Sci. Rep."},{"key":"19964_CR79","doi-asserted-by":"crossref","unstructured":"Keser, T. et al. High-Throughput and site-specific N-glycosylation analysis of human alpha-1-acid glycoprotein offers a great potential for new biomarker discovery. Mol. Cell. Proteomics 20, 0\u201315 (2021).","DOI":"10.1074\/mcp.RA120.002433"},{"key":"19964_CR80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coph.2018.04.002","volume":"41","author":"AP Black","year":"2018","unstructured":"Black, A. P. & Mehta, A. S. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Curr. Opin. Pharmacol. 41, 74\u201378 (2018).","journal-title":"Curr. Opin. Pharmacol."},{"key":"19964_CR81","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1158\/1055-9965.EPI-20-0005","volume":"29","author":"ND Parikh","year":"2020","unstructured":"Parikh, N. D. et al. Biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 29, 2495\u20132503 (2020).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"19964_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1002749","volume":"8","author":"R Anuradha","year":"2012","unstructured":"Anuradha, R. et al. Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease. PLoS Pathog. 8, 1\u20139 (2012).","journal-title":"PLoS Pathog."},{"key":"19964_CR83","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.ijpara.2018.04.002","volume":"48","author":"V Khatri","year":"2019","unstructured":"Khatri, V., Chauhan, N., Vishnoi, K. & Kalyanasundaram, R. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates. Int J Parasitol. 48, 773\u2013783 (2019).","journal-title":"Int J Parasitol."},{"key":"19964_CR84","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1021\/ac1027116","volume":"83","author":"MHJ Selman","year":"2011","unstructured":"Selman, M. H. J., Hemayatkar, M., Deelder, M. & Wuhrer, M. Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. Anal. Chem. 83, 2492\u20132499 (2011).","journal-title":"Anal. Chem."},{"key":"19964_CR85","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1021\/pr7008252","volume":"7","author":"A Ceroni","year":"2008","unstructured":"Ceroni, A. et al. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J. Proteome Res. 7, 1650\u20131659 (2008).","journal-title":"J. Proteome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19964-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19964-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19964-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T12:08:00Z","timestamp":1668859680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19964-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19964"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19964-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"10 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15763"}}